• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Microsphere-Enabled Modular Formation of Miniaturized In Vitro Breast Cancer Models.基于微球的模块化方法构建小型化体外乳腺癌模型。
Small. 2024 Apr;20(17):e2307365. doi: 10.1002/smll.202307365. Epub 2023 Nov 21.
2
Cryopreservable and tumorigenic three-dimensional tumor culture in porous poly(lactic-co-glycolic acid) microsphere.可冷冻保存且具有致瘤性的多孔聚乳酸-乙醇酸共聚物微球三维肿瘤培养物
Biomaterials. 2009 Sep;30(25):4227-32. doi: 10.1016/j.biomaterials.2009.04.025. Epub 2009 May 15.
3
Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits.聚乳酸-羟基乙酸共聚物微球控释血管内皮生长因子:体外特性分析及其在聚己内酯延胡索酸酯神经导管中的应用。
Acta Biomater. 2012 Feb;8(2):511-8. doi: 10.1016/j.actbio.2011.10.001. Epub 2011 Oct 7.
4
Poly(lactic-co-glycolic) acid/nanohydroxyapatite scaffold containing chitosan microspheres with adrenomedullin delivery for modulation activity of osteoblasts and vascular endothelial cells.载肾上腺髓质素壳聚糖微球的聚乳酸-羟基乙酸共聚物/纳米羟基磷灰石支架对成骨细胞和血管内皮细胞活性的调节作用。
Biomed Res Int. 2013;2013:530712. doi: 10.1155/2013/530712. Epub 2013 Jun 11.
5
Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancer.用于治疗乳腺癌的工程化抗HER2药物递送纳米系统。
Nanoscale. 2025 Apr 10;17(15):9436-9457. doi: 10.1039/d4nr03907f.
6
Injectable and porous PLGA microspheres that form highly porous scaffolds at body temperature.可注射且多孔的聚乳酸-羟基乙酸共聚物(PLGA)微球,其在体温下形成高度多孔的支架。
Acta Biomater. 2014 Dec;10(12):5090-5098. doi: 10.1016/j.actbio.2014.08.015. Epub 2014 Aug 23.
7
Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.不透射线复合材料的组成-性能关系:用于经动脉化疗栓塞的预载药物洗脱微球
J Biomater Appl. 2015 Jul;30(1):93-103. doi: 10.1177/0885328215572196. Epub 2015 Feb 16.
8
Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres.聚乳酸-羟基乙酸共聚物(PLGA)原材料对载药微球体外及体内性能的影响。
Drug Deliv Transl Res. 2025 Jan;15(1):185-202. doi: 10.1007/s13346-024-01577-y. Epub 2024 Apr 20.
9
Mechanism of drug release from double-walled PDLLA(PLGA) microspheres.双层 PDLLA(PLGA)微球中药物释放的机制。
Biomaterials. 2013 May;34(15):3902-11. doi: 10.1016/j.biomaterials.2013.02.015. Epub 2013 Feb 27.
10
Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering.通过微球递送在生物聚合物支架中形成生长因子梯度用于骨软骨组织工程
J Control Release. 2009 Mar 4;134(2):81-90. doi: 10.1016/j.jconrel.2008.10.021. Epub 2008 Nov 17.

本文引用的文献

1
3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.3D 仿生模型体外重建肿瘤微环境:球体、类器官和芯片上的肿瘤。
Adv Healthc Mater. 2023 Jul;12(18):e2202609. doi: 10.1002/adhm.202202609. Epub 2023 Mar 29.
2
Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration.乳腺癌细胞介导内皮细胞激活,促进血管性血友病因子释放、肿瘤黏附以及跨内皮迁移。
J Thromb Haemost. 2022 Oct;20(10):2350-2365. doi: 10.1111/jth.15794. Epub 2022 Jul 10.
3
Biomarkers for cancer-associated fibroblasts.癌症相关成纤维细胞的生物标志物。
Biomark Res. 2020 Nov 11;8(1):64. doi: 10.1186/s40364-020-00245-w.
4
Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers.基于间充质干细胞负载光响应亚微米载体的仿生药物传递平台。
Biomater Sci. 2020 Feb 21;8(4):1137-1147. doi: 10.1039/c9bm00926d. Epub 2019 Oct 4.
5
Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers.利用亚微米载体浸渍的间充质干细胞安全有效地递抗肿瘤药物。
ACS Appl Mater Interfaces. 2019 Apr 10;11(14):13091-13104. doi: 10.1021/acsami.8b22685. Epub 2019 Mar 27.
6
E-cadherin in contact inhibition and cancer.E-钙黏蛋白在接触抑制和癌症中的作用。
Oncogene. 2018 Aug;37(35):4769-4780. doi: 10.1038/s41388-018-0304-2. Epub 2018 May 21.
7
Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2.小白菊内酯可预防MDA-MB231细胞对阿霉素和米托蒽醌产生耐药性:核因子E2相关因子2的作用
Cell Death Discov. 2017 Dec 4;3:17078. doi: 10.1038/cddiscovery.2017.78. eCollection 2017.
8
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins.乳腺癌细胞的多柔比星耐药性是由细胞外基质蛋白介导的。
BMC Cancer. 2018 Jan 6;18(1):41. doi: 10.1186/s12885-017-3953-6.
9
A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening.一种多功能 3D 组织基质支架系统,用于肿瘤建模和药物筛选。
Sci Adv. 2017 Sep 13;3(9):e1700764. doi: 10.1126/sciadv.1700764. eCollection 2017 Sep.
10
CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.CD34在氧诱导性视网膜病变小鼠模型中促进病理性视网膜前新生血管形成。
PLoS One. 2016 Jun 28;11(6):e0157902. doi: 10.1371/journal.pone.0157902. eCollection 2016.

基于微球的模块化方法构建小型化体外乳腺癌模型。

Microsphere-Enabled Modular Formation of Miniaturized In Vitro Breast Cancer Models.

机构信息

Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.

Department of Respiratory Medicine, Zhongnan Hospital Wuhan University, Wuhan, Hubei, 361005, China.

出版信息

Small. 2024 Apr;20(17):e2307365. doi: 10.1002/smll.202307365. Epub 2023 Nov 21.

DOI:10.1002/smll.202307365
PMID:37990372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11045325/
Abstract

In search of effective therapeutics for breast cancers, establishing physiologically relevant in vitro models is of great benefit to facilitate the clinical translation. Despite extensive progresses, it remains to develop the tumor models maximally recapturing the key pathophysiological attributes of their native counterparts. Therefore, the current study aimed to develop a microsphere-enabled modular approach toward the formation of in vitro breast tumor models with the capability of incorporating various selected cells while retaining spatial organization. Poly (lactic-co-glycolic acid) microspheres (150-200 mm) with tailorable pore size and surface topography are fabricated and used as carriers to respectively lade with breast tumor-associated cells. Culture of cell-laden microspheres assembled within a customized microfluidic chamber allowed to form 3D tumor models with spatially controlled cell distribution. The introduction of endothelial cell-laden microspheres into cancer-cell laden microspheres at different ratios would induce angiogenesis within the culture to yield vascularized tumor. Evaluation of anticancer drugs such as doxorubicin and Cediranib on the tumor models do demonstrate corresponding physiological responses. Clearly, with the ability to modulate microsphere morphology, cell composition and spatial distribution, microsphere-enabled 3D tumor tissue formation offers a high flexibility to satisfy the needs for pathophysiological study, anticancer drug screening or design of personalized treatment.

摘要

为了寻找乳腺癌的有效治疗方法,建立生理相关的体外模型对于促进临床转化非常有益。尽管已经取得了广泛的进展,但仍需要开发最大限度地再现其天然对应物关键病理生理特征的肿瘤模型。因此,本研究旨在开发一种基于微球的模块化方法,用于体外乳腺癌模型的形成,该模型具有同时包含各种选定细胞的能力,同时保留空间组织。制备了具有可调节孔径和表面形貌的聚(乳酸-共-乙醇酸)微球(150-200μm),并用作载体制备负载有乳腺癌相关细胞的微球。在定制的微流控室中培养载有细胞的微球,允许在空间上控制细胞分布形成 3D 肿瘤模型。以不同比例将内皮细胞负载的微球引入到癌细胞负载的微球中,可在培养物中诱导血管生成,从而产生血管化肿瘤。在肿瘤模型上评估抗癌药物(如多柔比星和 Cediranib)的实验表明,这些药物具有相应的生理反应。显然,通过调节微球形态、细胞组成和空间分布的能力,基于微球的 3D 肿瘤组织形成提供了高度的灵活性,以满足病理生理学研究、抗癌药物筛选或个性化治疗设计的需求。